ArticleInternational journal of women's health2026
Circadian Biology and Gynecological Diseases: Genetic Mechanisms and Potential Therapeutic Targets Underlying the Causal Link Between Insomnia and Ovarian Cysts.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although circadian disruption has been implicated in gynecologic malignancies, genetic evidence for a causal relationship between insomnia and ovarian cysts remains lacking. The biological pathways linking sleep disturbance to ovarian pathology are therefore poorly understood, limiting mechanistic insights and therapeutic development. Methods: We employed a two-sample Mendelian Randomization (MR) framework using large-scale Genome-Wide Association Study (GWAS) datasets of European ancestry to examine the effects of seven sleep-related traits on five gynecologic outcome types. We further conducted transcriptomic analyses using Gene Expression Omnibus (GEO) datasets (GSE208668 and GSE7305) and performed molecular docking with 288 drug-like compounds to explore therapeutic targets. Results: MR identified a strong, unidirectional association between insomnia and increased ovarian cyst risk, with no evidence of reverse causality. Other sleep traits showed mixed effects across gynecologic outcomes. Single-nucleotide polymorphism (SNP)-mapped gene enrichment revealed involvement of neuronal signaling, circadian rhythm, and immune pathways. Three core genes (GFRA1, SORCS2, RASGRF2) were identified through overlap with ovarian cyst differentially expressed genes (DEGs) and were further supported by in silico docking with favorable predicted binding energies. Shared DEGs between insomnia and ovarian cyst samples were enriched in leukocyte activation, oxidative stress, and developmental processes. Conclusion: This multi-omics study provides genetic and molecular evidence that insomnia may contribute to ovarian cyst formation through circadian, synaptic, and immune mechanisms. The identified hub genes and druggable targets suggest circadian-aligned therapeutic strategies (chronotherapy), including sleep optimization, rhythm-timed pharmacotherapy, and melatonin-related modulation, as potential avenues for prevention and intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.